drugset / Trial / NCT04492319

Addition of Neostigmine to Levobupivacaine

NCT04492319

Completed 112 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic cord block is being a single injection technique, leading to a short postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as neostigmine.

Timeline

Start
2020-09-29
Primary completion
2023-11-23
Completion
2023-12-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 500 ug
Comparator Levobupivacaine Other / unclassified 0.5 %
Comparator Levobupivacaine Other / unclassified 19 ml

Indications

No indication recorded.